Investor Relations
Q3 2025 Codexis, Inc. Earnings Conference Call
Nov 6, 2025 4:30 pm EDT
Nov 6, 2025 4:30 pm EDT
View our latest Investor Presentation to find the most recent investor-related information.
Codexis’ Landmark Presentations Highlight Reproducibility and Performance Improvements of the ECO Synthesis Platform
Sign up today and receive company updates straight to your inbox.
Codexis is a leading enzyme engineering company powering scalable, sustainable solutions for therapeutic development. We unlock therapeutic possibilities previously out of reach — from next-gen RNA medicines to precision diagnostic enzymes. With our proprietary CodeEvolver® platform and ECO Synthesis™ platform, we create manufacturing solutions for challenges once thought unsolvable, delivering enzymes that outperform legacy methods across RNAi therapeutics, diagnostics, and small molecule manufacturing. Our enzyme-powered processes drive measurable impact with fewer impurities, faster timelines, and reduced waste and energy use across applications.
Codexis, Inc.
200 Penobscot Drive
Redwood City, California 94063
T: 650-421-8100
media@codexis.com
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States
M: 650-421-8399
ir@codexis.com
EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120-4100
T: 800-468-9716
https://www.shareowneronline.com